News

McDermott & Bull Recruits Chief Financial Officer for Human Longevity, Inc.

IRVINE, California, July 20, 2017McDermott & Bull, one of the largest executive search firms within the Hunt Scanlon Top 50 Recruiters list, as well as one of Forbes’ Best Executive Recruiting Firms, is pleased to announce the successful appointment of Saturnino “Nino” Fanlo as Chief Financial Officer with Human Longevity, Inc. (HLI), a genomics-based health intelligence company.

This executive recruiting engagement was conducted by Craig Lipus, Partner; Garrett Lipus, Principal Consultant; and Amanda Lange, Recruiting Associate at McDermott & Bull.  According to Craig Lipus, “Nino brings 30 years of experience in capital markets with Tier I firms, as well as a history of strategic and operational excellence.  Nino’s ideal background adds tremendous experience and credibility to an already impressive leadership team focused on the commercialization of this prestigious health intelligence company.  McDermott & Bull is thrilled to be associated with such a meaningful and dynamic organization.”

Fanlo joins HLI from Social Finance, Inc. (Sofi), the largest and fastest growing online lender, where he served as President and Chief Financial Officer.  He was a key leader at Sofi who worked hand in hand with the CEO and founder to design and build capital markets, loan sale, finance, and credit and loan operations.  Prior to Sofi, Fanlo held a series of high level leadership roles in well-respected financial services firms, including Golden Gate Capital, KKR Financial, and Wells Fargo.

Fanlo received his Bachelor of Economics from Haverford College, Haverford, PA.

About Human Longevity, Inc.

Human Longevity, Inc. (HLI) is the genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.  HLI combines the largest database of genomic and phenotypic data with machine learning to drive discoveries and revolutionize the practice of medicine.  HLI’s business areas include the HLI Health Nucleus, a genomic powered clinical research center which uses whole genome sequence analysis, advanced clinical imaging and innovative machine learning, along with curated personal health information, to deliver the most complete picture of individual health; HLIQ Whole Genome and HLIQ Oncology.

About McDermott & Bull

McDermott & Bull is a retained search firm that partners with leading companies to identify and recruit leaders for permanent and interim roles.  All of the practice leaders within the firm’s Executive Search business have deep executive experience and are uniquely positioned to address the dynamic leadership demands of public and private companies across nearly every industry.  McDermott & Bull’s Interim Leaders team is equipped to service the needs of its clients by placing senior-level executives into temporary roles during critical periods.  The firm’s Executive Network program provides valuable resources for and offers opportunities to build meaningful relationships with thousands of C-Suite and VP-level executives throughout the country.  The formation of McDermott & Bull Europe, which stemmed from the acquisition of Interconsultants Executive Search, gives the firm access to international insights and expertise and makes McDermott & Bull a true global player.